Background
Mark Holodniy, a researcher at Stanford University, worked on developing a method to measure HIV levels in blood — research partly funded by federal grants. As part of his employment, he signed a written agreement with Stanford in which he agreed to assign his inventions to the university. Later, while working at a private company called Cetus Corporation (later acquired by Roche Molecular Systems), Holodniy signed another agreement assigning his inventions to Cetus as well.
Stanford obtained patents on Holodniy’s HIV quantification methods and then sued Roche for infringement. Roche argued that Holodniy’s earlier assignment to Cetus — executed before his Stanford assignment took effect — transferred ownership of the invention to Cetus, and therefore Stanford lacked the full title needed to enforce the patents. Stanford countered that the Bayh-Dole Act of 1980 automatically vests ownership of federally funded inventions in universities.
The Court’s Holding
Chief Justice Roberts, writing for a 7-2 majority, held that the Bayh-Dole Act does not automatically transfer ownership of federally funded inventions to the contractor (the university). The Act’s language — providing that contractors “may elect to retain title” — presupposes that the title belongs to the inventor first. Federal patent law has long held that inventions initially belong to the inventor, and Congress did not override that default with Bayh-Dole.
Because Holodniy’s agreement with Cetus used the language “I will assign” (a present-tense promise to assign in the future), while his Stanford agreement used “I agree to assign” (also a future obligation), the Court analyzed which assignment came first. Since Holodniy had contractually committed to assign to Cetus before the Stanford obligation took effect, Cetus (and by acquisition, Roche) held a valid ownership interest, defeating Stanford’s patent claims.
Key Takeaways
- The Bayh-Dole Act does not automatically vest title to federally funded inventions in universities — it gives universities the option to elect to retain title after the inventor assigns it.
- Patent ownership begins with the inventor, and universities must use proper assignment agreements to secure title — relying on Bayh-Dole alone is insufficient.
- Timing matters: a prior contractual commitment to assign to a third party can defeat a subsequent employer’s claim to the same invention.
- Universities and research institutions should carefully audit employee assignment agreements, particularly for researchers who collaborate with private companies.
Why It Matters
This decision sent a warning to every research university in the country: Bayh-Dole is not a magic shield. Despite the Act’s goal of encouraging universities to commercialize federally funded research, the Court made clear that universities must actually obtain valid invention assignments from their researchers through proper contractual mechanisms.
The ruling has practical consequences for technology transfer offices, sponsored research agreements, and consulting arrangements. Researchers who collaborate with industry partners — or who join startups while employed by universities — can inadvertently create competing ownership claims. The case also highlighted the legal significance of precise drafting: “I will assign” versus “I hereby assign” can determine who ultimately owns a multimillion-dollar patent portfolio.
Your browser cannot display this PDF inline.
Download the full opinion (PDF)